Insider filing · ALZN
Milton C Ault Iii
Other
profile →
Alzamend Neuro, Inc.
ALZN · Healthcare · 11 filings in 24 months
ticker →
Milton C Ault Iii sold $344K of Alzamend Neuro (ALZN)
Executed Oct 6 2025, disclosed Oct 8 2025, 2 days later.
Value, as filed
$344K
139,412 sh across 2 lots
Executed
Oct 6 2025
the trade date, as filed
Disclosed
Oct 8 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MIMilton C Ault Iii (Other) filed 20 Form 4 reports in the trailing twelve months (15 purchases, 5 sales, 2 filed past the two-business-day deadline), most often in Alzamend Neuro, Inc. (ALZN). Across 11 priced purchase filings, the average 21-session return was +1.9% from execution and +4.9% from disclosure (delay-adjusted; derived). The largest single filing was $1.2M of UUU (205,000 sh × $6.00, as filed), executed Feb 4.
The name
ALZNHealthcare · Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenera…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Milton C Ault Iii in ALZN
ALZNPURCHASE
Alzamend Neuro, Inc.
$109K108,388 sh × $1.00
Exec Apr 14
Filed Aug 31 · 6:00 AM ET † ALZNPURCHASE Alzamend Neuro, Inc. $109K
108,388 sh × $1.00
Exec Apr 14
Filed Aug 31 · 6:00 AM ET † ALZNPURCHASE Alzamend Neuro, Inc. $109K
108,388 sh × $1.00
Exec Apr 14
Filed Apr 16 · 4:30 PM ET ALZNSALE Alzamend Neuro, Inc. $247K
101,394 sh × $2.44
Exec Oct 8 2025
Filed Oct 10 2025 · 5:30 PM ET ALZNSALE Alzamend Neuro, Inc. $161K
65,903 sh × $2.44
Exec Oct 3 2025
Filed Oct 3 2025 · 5:30 PM ET ALZNSALE Alzamend Neuro, Inc. $103K
43,238 sh × $2.38
Exec Sep 23 2025
Filed Sep 25 2025 · 5:30 PM ET ALZNSALE Alzamend Neuro, Inc. $181K
77,009 sh × $2.35
Exec Sep 19 2025
Filed Sep 23 2025 · 5:30 PM ET ALZNSALE Alzamend Neuro, Inc. $222K
100,000 sh × $2.22
Exec Jul 31 2025
Filed Aug 1 2025 · 5:30 PM ET